Dimitrios Angelis Presents Sparta Biomedical at LSI USA '24 Emerging MedTech Summit

March 21, 2024

The LSI USA 24 Emerging MedTech Summit is a prestigious gathering that brings together industry leaders, investors, and innovators in the field of medical technology. The summit serves as a platform for sharing knowledge, discussing emerging trends, and exploring potential collaborations. Dimitrios Angelis, representing Sparta Biomedical at the LSI USA summit for the third time, took the opportunity to present the company's latest achievements and future plans.

Dimitrios said that SPARTA Biomedical is pioneering an innovative medical solution to address the prevalent issue of osteoarthritis. The company's groundbreaking product, Ormi^TM, is an implant that uses a hydrogel material on a porous titanium base, a breakthrough innovation designed to restore motion to people suffering from knee problems. The promising device, which has already received FDA breakthrough designation, has resulted in over 3,300 people signing up for clinical trials set to commence shortly. The North Carolina-based company has received attention from media outlets like NBC affiliates in the Research Triangle and World Economic Forum. SPARTA Biomedical is steadfastly driven by its mission to change the world by improving patient lives and advancing the standard of care for osteoarthritis.

SPARTA Biomedical is presented for Plug and Play at Zimmer Biomet global headquarters in Warsaw Indiana. SPARTA Biomedical are being considered as a candidate for the accelerator Plug and Play.
‍